Related Experiment Videos
[Diagnostic progress in spinal muscular atrophy].
A Gergont1, M Kaciński, M Steczkowska-Klucznik
1Klinika Neurologii Dzieciecej Wydziału Lekarskiego Collegium Medicum Uniwersytetu Jagiellońskiego, ul. Wielicka 265, 30-663 Kraków. neupedkr@kki.net.pl
Przeglad Lekarski
|May 4, 2002
Summary
Molecular diagnostics have advanced spinal muscular atrophy (SMA) recognition. Genetic analysis confirms SMA in children, identifying specific gene deletions for improved diagnosis.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Context:
- Spinal muscular atrophy (SMA) is a common childhood neurodegenerative disorder.
- Diagnostic methods have evolved significantly, moving from muscle biopsy to genetic analysis.
- Understanding SMA's genetic basis, particularly the SMN gene, is crucial for diagnosis.
Purpose:
- To present the diagnostic results of SMA in 18 children.
- To highlight the transition from traditional muscle biopsy to molecular diagnostics.
- To evaluate the effectiveness of molecular analysis in confirming SMA phenotypes.
Summary:
- Muscle biopsy was the primary diagnostic tool for SMA between 1995-1997.
- Molecular studies, introduced in 1998, enabled confirmation of classical and non-classical SMA phenotypes.
- Genetic analysis confirmed SMA in 7 out of 18 children, identifying SMN gene exon 7 absence or deletions in SMN and NAIP genes.
Impact:
- Molecular diagnostics offer a more definitive and broader diagnostic capability for SMA.
- This advancement aids in understanding SMA's genetic mechanisms and variability.
- Improved diagnostic accuracy facilitates timely intervention and management for affected children.